AbbVie ABBV Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $3.64B-14.0% | $4.23B+75.1% | $2.42B-36.3% | $3.79B-10.2% | $4.23B-1.9% | ||
| $989M+3.6% | $955M-0.7% | $962M+3.0% | $934M-4.0% | $973M+6.8% | ||
| $21.22B+11.5% | $19.03B-8.8% | $20.86B+8.2% | $19.28B+17.6% | $16.4B-12.8% | ||
| $1.24B+2.5% | $1.21B+3.2% | $1.18B+12.6% | $1.04B+2.8% | $1.02B+4.3% | ||
| —— | —— | —— | —— | —— | ||
| -$6.48B+2.4% | -$6.64B+5.8% | -$7.05B+41.4% | -$12.05B-0.7% | -$11.97B+42.5% | ||
| $11.82B+1.4% | $11.66B+1.4% | $11.5B+1.4% | $11.34B+1.4% | $11.18B+1.4% | ||
| $1.51B+53.9% | $980M-26.6% | $1.34B-1.0% | $1.35B+0.2% | $1.35B-21.3% | ||
| —— | —— | —— | —— | —— | ||
| -$10.55B+17.1% | -$12.72B+17.5% | -$15.42B— | —— | —— | ||
| $4.22B+1,529% | -$295M+81.9% | -$1.63B+75.6% | -$6.66B+48.3% | -$12.89B-76.8% | ||
| $19.98B+12.1% | $17.82B-9.5% | $19.68B+7.9% | $18.24B+18.6% | $15.39B-13.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does AbbVie generate?
- AbbVie (ABBV) generated $21.2B in operating cash flow over the trailing twelve months.
- What is AbbVie's free cash flow?
- After $1.2B of capital expenditures, AbbVie's free cash flow was $20.0B over the trailing twelve months, up 29.9% year over year.
- Where does AbbVie's cash flow data come from?
- Every line is extracted from AbbVie's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
